NewcelX (NCEL) Debt Ratio (2019 - 2025)
NewcelX (NCEL) posted quarterly Debt Ratio of 0.03 for Q4 2025, down 90.44% year-over-year from 0.32 in Q4 2024, and down 90.44% quarter-over-quarter from 0.32 in Q4 2024.
NewcelX (NCEL) Debt Ratio (2019 - 2025) Analysis & Trends
NewcelX (NCEL) has reported Debt Ratio for 6 consecutive years, with 0.03 the latest figure, recorded in Q4 2025.
- In Q4 2025, Debt Ratio fell 90.44% year-over-year to 0.03; the TTM figure through Dec 2025 stood at 0.03 (down 90.44% YoY), while the FY2025 annual figure was 0.03, down 90.44% from the prior year.
- Debt Ratio slipped to 0.03 in Q4 2025 per NCEL's latest filing, from 0.32 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.32 in Q4 2024 and bottomed at 0.03 in Q4 2025.
- Historically, Debt Ratio has averaged 0.16 across 4 years, with a median of 0.13 in 2023.
- Annual changes were most pronounced in 2024 — Debt Ratio surged 148.69% — and 2025, when it slumped 90.44%.
- NewcelX's Debt Ratio stood at 0.08 in 2022, then jumped by 58.58% to 0.13 in 2023, then soared by 148.69% to 0.32 in 2024, then plunged by 90.44% to 0.03 in 2025.
- Business Quant data shows NCEL's Debt Ratio at 0.03 in Q4 2025, 0.32 in Q4 2024, and 0.22 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.47 |
| 10 | NewcelX | 12.54 Mn | 10.34 Mn | - | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.32 |
| Jun 30, 2024 | 0.22 |
| Dec 31, 2023 | 0.13 |
| Jun 30, 2023 | 0.12 |
| Dec 31, 2022 | 0.08 |
| Jun 30, 2022 | 0.17 |
| Dec 31, 2020 | 0.61 |
| Dec 31, 2019 | 0.22 |